Aytu BioScience Inc (AYTU)

NASDAQ
2.800
-0.040(-1.41%)
After Hours
2.850
+0.050(+1.786%)
- Real-time Data
  • Volume:
    671,360
  • Bid/Ask:
    2.800/2.850
  • Day's Range:
    2.790 - 2.920

AYTU Overview

Prev. Close
2.84
Day's Range
2.79-2.92
Revenue
57.01M
Open
2.85
52 wk Range
2.79-14
EPS
-2.76
Volume
671,360
Market Cap
78.25M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
529,404
P/E Ratio
-
Beta
-0.19
1-Year Change
-78.15%
Shares Outstanding
27,551,912
Next Earnings Date
Sep 22, 2021
What is your sentiment on Aytu BioScience Inc?
or
Market is currently closed. Voting is open during market hours.

Aytu BioScience Inc News

Aytu BioScience Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell

Aytu BioScience Inc Company Profile

Aytu BioScience Inc Company Profile

Employees
75

Aytu Biopharma, Inc., formerly Aytu BioScience, Inc., is a specialty pharmaceutical company. The Company markets a portfolio of prescription products addressing primary care and pediatric markets. The Company's primary prescription products treat attention deficit hyperactivity disorder (ADHD) and other common pediatric conditions. It markets ADHD products Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets, Cotempla XR-ODT (methylphenidate) extended-release orally disintegrating tablets, and Adzenys-ER (amphetamine) extended-release oral suspension. The Company's other pediatric products include Karbinal ER (carbinoxamine maleate), an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions, and Poly-Vi-Flor and Tri-Vi-Flor, two complementary fluoride-based prescription vitamin product lines containing combinations of fluoride and vitamins in formulations for infants and children with fluoride deficiency.

Read More
  • I buy 20k shares at 4$ and sell today at 4.3$ on fake pump.Waiting 3$ to new tradeStill no good news and perspectives
    0
    • à vomir cette action cà descend tout les jours.
      0
      • did you mean vommit?
        0
    • 2021.06.25. MM 4.73. Tgt 16 to RM16.50
      0
      • ready to 🚀🚀🚀....
        0
        • Is anyone here? :) if u like buy it at 6$ u like buy it at 4$
          2
          • Is anyone here? :) if u like buy it at 6$ u like buy it at 4$
            1
            • does anyone have a idee on when this will spike i dont know much about the project
              0
              • Spike Hunter 100% respect XD
                0
            • A person(s) who is willing to "talk down" or "drive down" a share price for fashionable, conformist, political reasons ? BELONGS in a gulag.
              0
              • The Stonks have better earnings than this one 🦆🦆🦆
                0
                • 🗑️ garbage buy AMC instead and 🍌🦍🦍🦍
                  0
                  • when will this be big?
                    2
                    • 2000 and never 🤣😂😆
                      0
                  • do we have any news on the latest project ?
                    0
                    • No. Only that dunces like to invoke aytu when they fashionably smear former President Trump because he mentioned UV therapy in one of his Press Briefings last year.
                      0
                    • No. Only that dunces like to invoke aytu when they fashionably smear former President Trump because he mentioned UV therapy in one of his Press Briefings last year.
                      0
                  • this be big when more people find out about it
                    1
                    • The merger wifh Neos dont seem to do any good to Aytu share price
                      1
                      • my target 20
                        3
                        • Good luck how many zero in front of the 20?
                          0
                      • 23,60 target price
                        0
                        • any target price any new for this stock
                          0
                          • scat
                            0
                            • Why this deep???25%
                              0
                              • 1-10 reverse split
                                0
                                • What just happened?!
                                  0
                                  • Ahh, they consolidated their stock.  Why was there no news on this?
                                    0
                                • Why does this stock have a strong sell? Any ideas?
                                  0
                                  • Where do you see this rating? Who issues it? IMO now exactly the time to buy.
                                    0
                                • Time to buy
                                  0
                                  • a mi mg este tipo de acciones para el trading, es un poco arriesgado pero se gana muy rapido y se pueden obtener buenos beneficios
                                    0
                                    • English pls
                                      0
                                  • Any news??
                                    0
                                    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.